Complex molecules – current developments
Gerrit Borchard · Generics and Biosimilars Initiative Journal · 2014
The pharmacological activity and toxicity of non-biological complex drugs (NBCDs) depends on their complex structure and composition. The regulatory approach leading to the registration of such drugs and their follow-on products, deemed 'nanosimilars', must be based on emerging scientific knowledge of NBCD